AI In Oncology Market 2024, By Component Type (Software Solutions, Hardware, Services), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Others), By Treatment Type (Chemotherapy, Radiotherapy, Immunotherapy, Others) and Region – Global Dynamics, Trends & Forecast

Number of pages: 200+  |  Report Format: PDF  |  Published date: July, 2024
Historical Years – 2018-2022  |  Base Year – 2023  |  Forecasted Years – 2024 to 2033

A new report titled “AI In Oncology Market – Forecast to 2033” by Eternal Markets, the global AI In Oncology industry is projected to grow at a compound annual growth rate (CAGR) of 28.6% from 2024 to 2033, reaching a value of USD 24,537.1 million by the end of the forecast period.

Overview

The global AI in oncology market is set to witness remarkable growth over the forecast period, driven by the increasing prevalence of cancer and the growing need for efficient diagnostic and treatment solutions. AI technologies are being integrated across various aspects of oncology, including early diagnosis, personalized treatment plans, and patient monitoring. North America currently holds the largest market share, attributed to its advanced healthcare infrastructure and significant investments in AI research and development.

Key Visions

  • Estimated CAGR: Around 28.6% over the forecast period (2024-2033).
  • Industry Size: Projected to reach USD 24,537.1 million by 2033 from USD 2,332.7 million in 2023.
  • Key Driver: Rising prevalence of cancer and the need for efficient diagnostic and treatment solutions.
  • By Component type, in 2023, Hardware segment held the largest market share.
  • Based on cancer type, breast cancer segment likely to be the largest revenue contributor in 2033.
  • Leading Region in 2023: North America due to its advanced healthcare infrastructure and significant investments in AI research and development.

Key Market Drivers

Increasing Prevalence of Cancer: The rising incidence of various cancer types is driving the demand for advanced diagnostic and treatment solutions.

Technological Advancements: Continuous advancements in AI technologies enhance the accuracy and efficiency of cancer diagnosis and treatment.

Personalized Medicine: Growing focus on personalized treatment plans that leverage AI for better patient outcomes.

Government Initiatives: Supportive government policies and funding for AI research in healthcare.

Efficiency and Cost-Effectiveness: AI solutions offer significant improvements in efficiency and cost-effectiveness in oncology care.

Restraining Factors

Data Privacy Concerns: Issues related to data privacy and security can limit the adoption of AI technologies.

Lack of Skilled Workforce: The need for a skilled workforce to manage and operate AI systems.

Technical Limitations: Limitations in AI technology, such as data processing capabilities and accuracy.

Future Scope

Emerging Markets Growth: Significant growth potential in Asia-Pacific and Latin America due to increasing adoption of AI technologies and rising healthcare investments.

Technological Innovations: Ongoing innovations in AI to improve early cancer detection, treatment planning, and patient monitoring.

Collaborations and Partnerships: Increased collaborations between AI technology providers and healthcare institutions to enhance oncology care.

Regulatory Support: Supportive regulatory frameworks promoting the integration of AI in healthcare.

Expansion of AI Applications: Broader applications of AI across various cancer types and treatment stages.

Major Strategies adopted by key market players.

  • Agreements, Collaborations, and Partnerships: 32%
  • Acquisitions: 14%
  • New Product Launch: _%
  • Other Developments: _%

Geographical Analysis

  • North America held the largest market share in 2023 due to its advanced healthcare infrastructure, high adoption rate of AI solutions, and significant investments in AI research and development. The U.S. is a major contributor to the market growth in this region.
  • Asia-Pacific is expected to witness significant growth during the forecast period due to increasing adoption of AI technologies in the healthcare sector, rising cancer incidence, and expanding healthcare infrastructure. Countries like China, Japan, and India are key contributors to the market expansion in this region.

Recent Developments

  • 2023: GE Healthcare launched a new AI-powered imaging system for early cancer detection.
  • 2022: IBM announced a partnership with a leading oncology center to develop AI-driven personalized cancer treatment solutions.
  • 2021: NVIDIA Corporation introduced an AI-based platform for real-time cancer diagnosis and treatment planning.
  • 2020: Siemens Healthcare GmbH expanded its AI capabilities in oncology by acquiring a leading AI startup focused on cancer treatment.

Scope of the Report:

Global AI In Oncology Market, By Component Type

  • Software Solutions
  • Hardware
  • Services

Global AI In Oncology Market, By Cancer Type

  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Brain Tumor
  • Others

Global AI In Oncology Market, By Treatment Type

  • Chemotherapy
  • Radiotherapy
  • Immunotherapy
  • Others

Global AI In Oncology Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • GCC
    • Israel
    • South Africa
    • Rest of MEA

Companies Profiled

● GE HealthCare
● IBM
● NVIDIA Corporation
● Median Technologies
● Siemens Healthcare GmbH
● Intel Corporation
● PathAI
● Digital Diagnostics Inc.
● Azra AI
● ConcertAI
● Other key players

*The report scope shall be customized as per the requirements

Chapter 1 Global AI In Oncology Market Overview
1.1 Introduction
1.2 Drivers for AI In Oncology Market
1.3 Restraints for AI In Oncology Market
1.4 Opportunities for AI In Oncology Market
1.5 Trends for AI In Oncology Market
1.6 Macro-economic Factors
1.7 Regulatory Framework
1.8 Opportunity Map Analysis
1.9 Opportunity Orbits
1.10 Market Investment Feasibility Index
1.11 PEST Analysis
1.12 PORTER’S Five Force Analysis
1.13 Go to Market Strategy
1.14 Marketing Strategy
1.15 Technology Roadmap
1.16 Advances in product/services adoption worldwide
1.17 Regional Market Share and BPS Analysis
Chapter 2 Global AI In Oncology Market Competitive Analysis
2.1 Market Competition Scenario Analysis, By Company
2.2 Competitor Landscape
2.3 Major Strategies adopted by key market players (2020-2022)
2.4 Recent Developments/Investments/Announcements
2.5 Company Profiles
2.5.1 GE HealthCare
2.5.1.1 Company Overview
2.5.1.2 Business Description
2.5.1.3 Product Portfolio
2.5.1.4 Key Financials
2.5.1.5 Company Presence & Business Segment Analysis – 2022
2.5.1.6 Key Developments
2.5.1.7 SWOT Analysis
2.5.2 IBM
2.5.2.1 Company Overview
2.5.2.2 Business Description
2.5.2.3 Product Portfolio
2.5.2.4 Key Financials
2.5.2.5 Company Presence & Business Segment Analysis – 2022
2.5.2.6 Key Developments
2.5.2.7 SWOT Analysis
2.5.3 NVIDIA Corporation
2.5.3.1 Company Overview
2.5.3.2 Business Description
2.5.3.3 Product Portfolio
2.5.3.4 Key Financials
2.5.3.5 Company Presence & Business Segment Analysis – 2022
2.5.3.6 Key Developments
2.5.3.7 SWOT Analysis
2.5.4 Median Technologies
2.5.4.1 Company Overview
2.5.4.2 Business Description
2.5.4.3 Product Portfolio
2.5.4.4 Key Financials
2.5.4.5 Company Presence & Business Segment Analysis – 2022
2.5.4.6 Key Developments
2.5.4.7 SWOT Analysis
2.5.5 Siemens Healthcare GmbH
2.5.5.1 Company Overview
2.5.5.2 Business Description
2.5.5.3 Product Portfolio
2.5.5.4 Key Financials
2.5.5.5 Company Presence & Business Segment Analysis – 2022
2.5.5.6 Key Developments
2.5.5.7 SWOT Analysis
2.5.6 Intel Corporation
2.5.6.1 Company Overview
2.5.6.2 Business Description
2.5.6.3 Product Portfolio
2.5.6.4 Key Financials
2.5.6.5 Company Presence & Business Segment Analysis – 2022
2.5.6.6 Key Developments
2.5.6.7 SWOT Analysis
2.5.7 PathAI
2.5.7.1 Company Overview
2.5.7.2 Business Description
2.5.7.3 Product Portfolio
2.5.7.4 Key Financials
2.5.7.5 Company Presence & Business Segment Analysis – 2022
2.5.7.6 Key Developments
2.5.7.7 SWOT Analysis
2.5.8 Digital Diagnostics Inc.
2.5.8.1 Company Overview
2.5.8.2 Business Description
2.5.8.3 Product Portfolio
2.5.8.4 Key Financials
2.5.8.5 Company Presence & Business Segment Analysis – 2022
2.5.8.6 Key Developments
2.5.8.7 SWOT Analysis
2.5.9 Azra AI
2.5.9.1 Company Overview
2.5.9.2 Business Description
2.5.9.3 Product Portfolio
2.5.9.4 Key Financials
2.5.9.5 Company Presence & Business Segment Analysis – 2022
2.5.9.6 Key Developments
2.5.9.7 SWOT Analysis
2.5.10 ConcertAI
2.5.10.1 Company Overview
2.5.10.2 Business Description
2.5.10.3 Product Portfolio
2.5.10.4 Key Financials
2.5.10.5 Company Presence & Business Segment Analysis – 2022
2.5.10.6 Key Developments
2.5.10.7 SWOT Analysis
Chapter 3 Global AI In Oncology Market Overview
3.1 Global AI In Oncology Market Outlook (2017-2032)
3.1.1 Global AI In Oncology Market Value (US$ Mn) and Volume (Units) (2017-2023)
3.1.2 Global AI In Oncology Market Value (US$ Mn) and Volume (Units) (2024-2032)
3.2 Global AI In Oncology Market by Region
3.2.1 Global AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
3.2.2 Global AI In Oncology Market Attractiveness Analysis by Region, 2023–2032
3.3 Global AI In Oncology Market by Component Type
3.3.1 Global AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Component Type (2017-2032)
3.3.2 Global AI In Oncology Market Attractiveness Analysis by Component Type, 2023–2032
3.3.3 Global AI In Oncology Market Attractiveness Analysis by Region, 2023–2032
3.4 Global AI In Oncology Market by Application
3.4.1 Global AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2032)
3.4.2 Global AI In Oncology Market Attractiveness Analysis by Application, 2023–2032
3.5 Global AI In Oncology Market Value (US$ Mn) and Volume (Units) by Region
3.5.1 Global AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
3.5.2 Global AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
3.6 Global AI In Oncology Market Value (US$ Mn) and Volume (Units) by Component Type
3.6.1 Global AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Component Type (2017-2023)
3.6.2 Global AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Component Type (2024-2032)
3.7 Global AI In Oncology Market Value (US$ Mn) and Volume (Units) by Application
3.7.1 Global AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2023)
3.7.2 Global AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Application (2024-2032)
3.8 Global AI In Oncology Market Y-o-Y Growth Rate Comparison 2018–2032
3.8.1 Global AI In Oncology Market Y-o-Y Growth Rate by Region
3.8.2 Global AI In Oncology Market Y-o-Y Growth Rate by Component Type
3.8.3 Global AI In Oncology Market Y-o-Y Growth Rate by Application
3.9 Global AI In Oncology Market Share Comparison 2017–2032
3.9.1 Global AI In Oncology Market Share by Region
3.9.2 Global AI In Oncology Market Share by Component Type
3.9.3 Global AI In Oncology Market Share by Application
Chapter 4 North America AI In Oncology Market Overview
4.1 North America Market Snapshot
4.1.1 Regional Overview
4.1.1.1 US
4.1.1.2 Canada
4.1.1.3 Mexico
4.2 North America AI In Oncology Market Outlook (2017-2032)
4.2.1 North America AI In Oncology Market Value (US$ Mn) and Volume (Units) (2017-2023)
4.2.2 North America AI In Oncology Market Value (US$ Mn) and Volume (Units) (2024-2032)
4.3 North America AI In Oncology Market by Region
4.3.1 North America AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
4.3.2 North America AI In Oncology Market Attractiveness Analysis by Region, 2023–2032
4.4 North America AI In Oncology Market by Component Type
4.4.1 North America AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Component Type (2017-2032)
4.4.2 North America AI In Oncology Market Attractiveness Analysis by Component Type, 2023–2032
4.4.3 North America AI In Oncology Market Attractiveness Analysis by Region, 2023–2032
4.5 North America AI In Oncology Market by Application
4.5.1 North America AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2032)
4.5.2 North America AI In Oncology Market Attractiveness Analysis by Application, 2023–2032
4.6 North America AI In Oncology Market Value (US$ Mn) and Volume (Units) by Region
4.6.1 North America AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
4.6.2 North America AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
4.7 North America AI In Oncology Market Value (US$ Mn) and Volume (Units) by Component Type
4.7.1 North America AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Component Type (2017-2023)
4.7.2 North America AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Component Type (2024-2032)
4.8 North America AI In Oncology Market Value (US$ Mn) and Volume (Units) by Application
4.8.1 North America AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2023)
4.8.2 North America AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Application (2024-2032)
4.9 North America AI In Oncology Market Y-o-Y Growth Rate Comparison 2018–2032
4.9.1 North America AI In Oncology Market Y-o-Y Growth Rate by Region
4.9.2 North America AI In Oncology Market Y-o-Y Growth Rate by Component Type
4.9.3 North America AI In Oncology Market Y-o-Y Growth Rate by Application
4.1 North America AI In Oncology Market Share Comparison 2017–2032
4.10.1 North America AI In Oncology Market Share by Region
4.10.2 North America AI In Oncology Market Share by Component Type
4.10.3 North America AI In Oncology Market Share by Application
Chapter 5 Europe AI In Oncology Market Overview
5.1 Europe Market Snapshot
5.1.1 Regional Overview
5.1.1.1 Germany
5.1.1.2 United Kingdom
5.1.1.3 France
5.1.1.4 Italy
5.1.1.5 Spain
5.1.1.6 Russia
5.1.1.7 Rest of Europe
5.2 Europe AI In Oncology Market Outlook (2017-2032)
5.2.1 Europe AI In Oncology Market Value (US$ Mn) and Volume (Units) (2017-2023)
5.2.2 Europe AI In Oncology Market Value (US$ Mn) and Volume (Units) (2024-2032)
5.3 Europe AI In Oncology Market by Region
5.3.1 Europe AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
5.3.2 Europe AI In Oncology Market Attractiveness Analysis by Region, 2023–2032
5.4 Europe AI In Oncology Market by Component Type
5.4.1 Europe AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Component Type (2017-2032)
5.4.2 Europe AI In Oncology Market Attractiveness Analysis by Component Type, 2023–2032
5.4.3 Europe AI In Oncology Market Attractiveness Analysis by Region, 2023–2032
5.5 Europe AI In Oncology Market by Application
5.5.1 Europe AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2032)
5.5.2 Europe AI In Oncology Market Attractiveness Analysis by Application, 2023–2032
5.6 Europe AI In Oncology Market Value (US$ Mn) and Volume (Units) by Region
5.6.1 Europe AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
5.6.2 Europe AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
5.7 Europe AI In Oncology Market Value (US$ Mn) and Volume (Units) by Component Type
5.7.1 Europe AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Component Type (2017-2023)
5.7.2 Europe AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Component Type (2024-2032)
5.8 Europe AI In Oncology Market Value (US$ Mn) and Volume (Units) by Application
5.8.1 Europe AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2023)
5.8.2 Europe AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Application (2024-2032)
5.9 Europe AI In Oncology Market Y-o-Y Growth Rate Comparison 2018–2032
5.9.1 Europe AI In Oncology Market Y-o-Y Growth Rate by Region
5.9.2 Europe AI In Oncology Market Y-o-Y Growth Rate by Component Type
5.9.3 Europe AI In Oncology Market Y-o-Y Growth Rate by Application
5.1 Europe AI In Oncology Market Share Comparison 2017–2032
5.10.1 Europe AI In Oncology Market Share by Region
5.10.2 Europe AI In Oncology Market Share by Component Type
5.10.3 Europe AI In Oncology Market Share by Application
Chapter 6 Asia Pacific AI In Oncology Market Overview
6.1 Asia Pacific Market Snapshot
6.1.1 Regional Overview
6.1.1.1 China
6.1.1.2 India
6.1.1.3 Japan
6.1.1.4 Australia
6.1.1.5 Rest of Asia Pacific
6.2 Asia Pacific AI In Oncology Market Outlook (2017-2032)
6.2.1 Asia Pacific AI In Oncology Market Value (US$ Mn) and Volume (Units) (2017-2023)
6.2.2 Asia Pacific AI In Oncology Market Value (US$ Mn) and Volume (Units) (2024-2032)
6.3 Asia Pacific AI In Oncology Market by Region
6.3.1 Asia Pacific AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
6.3.2 Asia Pacific AI In Oncology Market Attractiveness Analysis by Region, 2023–2032
6.4 Asia Pacific AI In Oncology Market by Component Type
6.4.1 Asia Pacific AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Component Type (2017-2032)
6.4.2 Asia Pacific AI In Oncology Market Attractiveness Analysis by Component Type, 2023–2032
6.4.3 Asia Pacific AI In Oncology Market Attractiveness Analysis by Region, 2023–2032
6.5 Asia Pacific AI In Oncology Market by Application
6.5.1 Asia Pacific AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2032)
6.5.2 Asia Pacific AI In Oncology Market Attractiveness Analysis by Application, 2023–2032
6.6 Asia Pacific AI In Oncology Market Value (US$ Mn) and Volume (Units) by Region
6.6.1 Asia Pacific AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
6.6.2 Asia Pacific AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
6.7 Asia Pacific AI In Oncology Market Value (US$ Mn) and Volume (Units) by Component Type
6.7.1 Asia Pacific AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Component Type (2017-2023)
6.7.2 Asia Pacific AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Component Type (2024-2032)
6.8 Asia Pacific AI In Oncology Market Value (US$ Mn) and Volume (Units) by Application
6.8.1 Asia Pacific AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2023)
6.8.2 Asia Pacific AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Application (2024-2032)
6.9 Asia Pacific AI In Oncology Market Y-o-Y Growth Rate Comparison 2018–2032
6.9.1 Asia Pacific AI In Oncology Market Y-o-Y Growth Rate by Region
6.9.2 Asia Pacific AI In Oncology Market Y-o-Y Growth Rate by Component Type
6.9.3 Asia Pacific AI In Oncology Market Y-o-Y Growth Rate by Application
6.1 Asia Pacific AI In Oncology Market Share Comparison 2017–2032
6.10.1 Asia Pacific AI In Oncology Market Share by Region
6.10.2 Asia Pacific AI In Oncology Market Share by Component Type
6.10.3 Asia Pacific AI In Oncology Market Share by Application
Chapter 7 South America AI In Oncology Market Overview
7.1 South America Market Snapshot
7.1.1 Regional Overview
7.1.1.1 Brazil
7.1.1.2 Argentina
7.1.1.3 Rest of South America
7.2 South America AI In Oncology Market Outlook (2017-2032)
7.2.1 South America AI In Oncology Market Value (US$ Mn) and Volume (Units) (2017-2023)
7.2.2 South America AI In Oncology Market Value (US$ Mn) and Volume (Units) (2024-2032)
7.3 South America AI In Oncology Market by Region
7.3.1 South America AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
7.3.2 South America AI In Oncology Market Attractiveness Analysis by Region, 2023–2032
7.4 South America AI In Oncology Market by Component Type
7.4.1 South America AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Component Type (2017-2032)
7.4.2 South America AI In Oncology Market Attractiveness Analysis by Component Type, 2023–2032
7.4.3 South America AI In Oncology Market Attractiveness Analysis by Region, 2023–2032
7.5 South America AI In Oncology Market by Application
7.5.1 South America AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2032)
7.5.2 South America AI In Oncology Market Attractiveness Analysis by Application, 2023–2032
7.6 South America AI In Oncology Market Value (US$ Mn) and Volume (Units) by Region
7.6.1 South America AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
7.6.2 South America AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
7.7 South America AI In Oncology Market Value (US$ Mn) and Volume (Units) by Component Type
7.7.1 South America AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Component Type (2017-2023)
7.7.2 South America AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Component Type (2024-2032)
7.8 South America AI In Oncology Market Value (US$ Mn) and Volume (Units) by Application
7.8.1 South America AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2023)
7.8.2 South America AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Application (2024-2032)
7.9 South America AI In Oncology Market Y-o-Y Growth Rate Comparison 2018–2032
7.9.1 South America AI In Oncology Market Y-o-Y Growth Rate by Region
7.9.2 South America AI In Oncology Market Y-o-Y Growth Rate by Component Type
7.9.3 South America AI In Oncology Market Y-o-Y Growth Rate by Application
7.1 South America AI In Oncology Market Share Comparison 2017–2032
7.10.1 South America AI In Oncology Market Share by Region
7.10.2 South America AI In Oncology Market Share by Component Type
7.10.3 South America AI In Oncology Market Share by Application
Chapter 8 Middle East and Africa AI In Oncology Market Overview
8.1 Middle East and Africa Market Snapshot
8.1.1 Regional Overview
8.1.1.1 GCC
8.1.1.2 South Africa
8.1.1.3 Israel
8.1.1.4 Rest of Middle East and Africa
8.2 Middle East and Africa AI In Oncology Market Outlook (2017-2032)
8.2.1 Middle East and Africa AI In Oncology Market Value (US$ Mn) and Volume (Units) (2017-2023)
8.2.2 Middle East and Africa AI In Oncology Market Value (US$ Mn) and Volume (Units) (2024-2032)
8.3 Middle East and Africa AI In Oncology Market by Region
8.3.1 Middle East and Africa AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
8.3.2 Middle East and Africa AI In Oncology Market Attractiveness Analysis by Region, 2023–2032
8.4 Middle East and Africa AI In Oncology Market by Component Type
8.4.1 Middle East and Africa AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Component Type (2017-2032)
8.4.2 Middle East and Africa AI In Oncology Market Attractiveness Analysis by Component Type, 2023–2032
8.4.3 Middle East and Africa AI In Oncology Market Attractiveness Analysis by Region, 2023–2032
8.5 Middle East and Africa AI In Oncology Market by Application
8.5.1 Middle East and Africa AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2032)
8.5.2 Middle East and Africa AI In Oncology Market Attractiveness Analysis by Application, 2023–2032
8.6 Middle East and Africa AI In Oncology Market Value (US$ Mn) and Volume (Units) by Region
8.6.1 Middle East and Africa AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
8.6.2 Middle East and Africa AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
8.7 Middle East and Africa AI In Oncology Market Value (US$ Mn) and Volume (Units) by Component Type
8.7.1 Middle East and Africa AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Component Type (2017-2023)
8.7.2 Middle East and Africa AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Component Type (2024-2032)
8.8 Middle East and Africa AI In Oncology Market Value (US$ Mn) and Volume (Units) by Application
8.8.1 Middle East and Africa AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Application (2017-2023)
8.8.2 Middle East and Africa AI In Oncology Market Value (US$ Mn) and Volume (Units) Comparison by Application (2024-2032)
8.9 Middle East and Africa AI In Oncology Market Y-o-Y Growth Rate Comparison 2018–2032
8.9.1 Middle East and Africa AI In Oncology Market Y-o-Y Growth Rate by Region
8.9.2 Middle East and Africa AI In Oncology Market Y-o-Y Growth Rate by Component Type
8.9.3 Middle East and Africa AI In Oncology Market Y-o-Y Growth Rate by Application
8.1 Middle East and Africa AI In Oncology Market Share Comparison 2017–2032
8.10.1 Middle East and Africa AI In Oncology Market Share by Region
8.10.2 Middle East and Africa AI In Oncology Market Share by Component Type
8.10.3 Middle East and Africa AI In Oncology Market Share by Application
Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

License

Single User, Corporate User, Data Pack / Excel
Single User
$3,499
Corporate User
$6,999
Data Pack / Excel
$999
Compare Added ♡ Add to Wishlist♥ Browse Wishlist

Related products

Compare Products
No products were added to compare list
Return to Shop
Caffeine Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Milk Powder Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Instant Coffee Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Collagen Peptide and Gelatin Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Electrolyte Drinks Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Food Colors Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Used Cooking Oil Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Nutritional Food and Drink Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Dietary Fibers Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Luxury Wines and Spirits Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Luxury Wines and Spirits Market 2024, Global Dynamics, Trends & Forecast
VIEW DETAILS